Q2 2025 · 13F-HR
Blue Water Life Science Advisors, LPholdings as filed
Filed 2025-08-14 · accession 0001420506-25-002029
$126.3M
Reported value
8
Positions
2025-06-30
Period end
The Brief · Blue Water Life Science Advisors, LP · Q2 2025
AI · grounded in 13F
Blue Water Life Science Advisors, LP established a new position in NTRA valued at $28.1M. The fund also initiated new stakes in ADPT for $24.9M and GH for $22.8M. Additional new positions include CDNA, TXG, and PSNL.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 632307104 | NTRA | NATERA INC | $28.1M | 22.3% | 166,494 | Common | SOLE |
| 00650F109 | ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $25.0M | 19.8% | 2,145,145 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $22.8M | 18.1% | 439,047 | Common | SOLE |
| 14167L103 | CDNA | CAREDX INC | $14.1M | 11.2% | 724,014 | Common | SOLE |
| 88025U109 | TXG | 10X GENOMICS INC-CLASS A | $12.7M | 10.1% | 1,100,720 | Common | SOLE |
| 71535D106 | PSNL | PERSONALIS INC | $11.0M | 8.70% | 1,676,300 | Common | SOLE |
| 74766Q101 | QTRX | QUANTERIX CORP | $6.4M | 5.04% | 957,747 | Common | SOLE |
| 00974H104 | — | AKOYA BIOSCIENCES INC | $6.1M | 4.83% | 4,697,785 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.